CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- 4 Grant or award SVP, Business Development acquired 1,876 shares (grant or award)
- 4 Grant or award SVP & CCO acquired 2,010 shares (grant or award)
- 4 Grant or award EVP & CFO acquired 12,063 shares (grant or award)
- 4 Grant or award EVP & Gen. Counsel & Sec. acquired 10,723 shares (grant or award)
- 4 Grant or award EVP, Global Commercial Ops acquired 13,403 shares (grant or award)
- 4 Grant or award Chairman, CEO and President acquired 42,657 shares (grant or award)
- 4 Grant or award VP, Finance & CAO acquired 938 shares (grant or award)
- 4 Open-market sale EVP, Operations sold 54,792 shares at $379.12 ($20,772,595)
- 144 Insider Sale of Securities
- 25-NSE Other Notification of Removal from Listing
- 4 Open-market sale VP, Finance & CAO sold 1,000 shares at $375.79 ($375,790)
- 8-K Event Material agreement
- 144 Insider Sale of Securities
- 424B2 Offering Prospectus
- FWP Offering Free Writing Prospectus
- 424B3 Offering Prospectus
- S-3ASR Offering Registration Statement
- 10-K Report Annual Report
- 4 Shares withheld for taxes EVP, Research and Development gave up 3,104 shares (to pay taxes)
- 8-K Event Results of operations
Page 6 of 161 · 3,201 filings